Manage episode 337510363 series 3382249
Dr. Wagner is a clinical nephrologist. He is the Director of the Kidney Institute of New Mexico as well as being the acting Associate Chief of Research and Renal Section Chief for the VA in Albuquerque.
In this episode we discuss recent evidence urging caution over the use of gadolinium based contrast agents.
To fund Dr. Wagner’s work you can donate to the Kidney Institute of New Mexico at
Reveal Pharmaceuticals, Gadolinium-free MRI contrast agents products.
Peter Caravan PhD. Director, Institute for Innovation in Imaging Massachusetts and Associate Professor of Radiology at Harvard Medical School.
The FDA adverse event reporting system
Gadolinium-based contrast agents: why nephrologists need to be concerned